Fundraising Fox

Onkologic

Ellicott City, US · Founded 2021 · Delaware corporation

OnKologic (Enable Life Sciences) develops Enable-NK cell culture media and a 10x concentrated supplement for expanding Natural Killer (NK) cells, used by NK cell research groups and in immuno-oncology cell therapy development. The products aim to improve NK cell performance metrics such as cytotoxicity, transduction efficiency, and cryopreservation for cancer research applications.

Founders & leadership

Onkologic was founded in 2021 by Rachit Ohri.

RO
Rachit OhriCEO and Founder
CG
Chandni Gupta OhriNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$305K disclosed across 1 round · 2022

$305KraisedJul 2022 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Chandni Gupta OhriDirector, Promoter
  • Rachit OhriExecutive Officer, Director, Promoter
Amount sold
$305K
Minimum investment
$15K
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 1

by search overlap

Companies competing with Onkologic for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Onkologic do?
OnKologic (Enable Life Sciences) develops Enable-NK cell culture media and a 10x concentrated supplement for expanding Natural Killer (NK) cells, used by NK cell research groups and in immuno-oncology cell therapy development. The products aim to improve NK cell performance metrics such as cytotoxicity, transduction efficiency, and cryopreservation for cancer research applications.
Who founded Onkologic?
Onkologic was founded by Rachit Ohri in 2021.
How much funding has Onkologic raised?
Onkologic has disclosed $305K raised across 1 round.
Where is Onkologic headquartered?
Onkologic is headquartered in Ellicott City, US.